EUVIMEDEUVIMED entdecken
Crossref

Does choice of anesthesia during stage 1 sacral neuromodulation testing influence outcomes?

Brendan T Waldoch iD, Danyon J Anderson, Sydney A Narveson, R Corey O'Connor iD, Michael L Guralnick iD

Neurourology and Urodynamics · 2024

DOI: 10.1002/nau.25393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Brendan T Waldoch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Electric Stimulation Therapy, Urinary Bladder, Overactive, Anesthesia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Staged sacral neuromodulation (SNM) testing has been shown to have a high rate of progression to permanent implantation for the management of voiding dysfunction. Stage 1 lead placement (SNM‐I) can be performed under monitored anesthesia care (MAC) or general anesthesia (GA). MAC allows for interpretation of sensory and motor responses to optimize lead placement while GA only permits for motor assessment. However, patient discomfort and movement can make lead placement challenging during MAC. Herein we evaluate whether the anesthesia type impacts the progression rate to permanent implantation (SNM‐II). Materials and Methods A retrospective chart review was performed for patients who underwent SNM‐I in the operating room for wet overactive bladder between 2005 and 2023. Patients were divided into two groups based on the type of anesthesia used, MAC or GA. Clinical variables and progression to SNM‐II were compared between cohorts. Progression to SNM‐II was based on ≥50% symptomatic improvement during a 1−2 week trial period following SNM‐I.

Results

Of 121 patients included in the study, 95 (79%) underwent MAC and 26 (21%) GA for SNM‐I. No difference in the progression rate to SNM‐II was noted between groups (MAC, 68/95 patients, 72%; GA, 19/26, 73%; p = 0.39). We also found no difference when comparing the GA group to the 26 most recent MAC patients (MAC, 20/26 patients, 77%; GA, 19/26, 73%; p = 0.48).

Conclusion

Types of anesthesia for SNM‐I did not affect rate of progression to SNM‐II. The result lends support to the reliance on motor responses alone for lead placement during SNM‐I.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Electric Stimulation TherapyUrinary Bladder, OveractiveAnesthesiaHumansRetrospective StudiesSacrumTreatment Outcome

Stichwörter der Autor:innen

anesthesiaoveractive bladdersacral neuromodulationurge urinary incontinence

Autor:innen und Institutionen

  • Department of Urology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Department of Urology, Loma Linda University Health, Loma Linda, California, USA.
  • Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Brendan T Waldoch, R Corey O'Connor, Michael L Guralnick

Zitieren

APA

Waldoch, B. T., Anderson, D. J., Narveson, S. A., O'Connor, R. C., & Guralnick, M. L. (2024). Does choice of anesthesia during stage 1 sacral neuromodulation testing influence outcomes?. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25393

Vancouver

Waldoch BT, Anderson DJ, Narveson SA, O'Connor RC, Guralnick ML. Does choice of anesthesia during stage 1 sacral neuromodulation testing influence outcomes?. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25393

BibTeX
@article{Waldoch2024,
  author = {Waldoch, Brendan T and Anderson, Danyon J and Narveson, Sydney A and O'Connor, R Corey and Guralnick, Michael L},
  title = {Does choice of anesthesia during stage 1 sacral neuromodulation testing influence outcomes?},
  journal = {Neurourology and Urodynamics},
  year = {2024},
  doi = {10.1002/nau.25393}
}
Kostenlos starten →